Extracellular vesicles derived from mesenchymal stem cells alleviate renal fibrosis via the miR-99b-5p/mTOR/autophagy axis in diabetic kidney disease
Abstract Background Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) globally, presenting a significant therapeutic challenge. Extracellular vesicles (EVs) from mesenchymal stem cells (MSCs) have emerged as promising therapeutic agents. This study explored the the...
Saved in:
| Main Authors: | Rongrong Li, Hongyan Tao, Kai Pan, Rui Li, Zhikun Guo, Xiaoniao Chen, Zongjin Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Stem Cell Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13287-025-04265-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mTOR pathway: A key player in diabetic nephropathy progression and therapeutic targets
by: Jingxuan Shi, et al.
Published: (2025-03-01) -
Glomerular mesangial derived extracellular vesicles deteriorate diabetic kidney disease via miR-3147/PRKAR2B axis
by: Jiayan Zhang, et al.
Published: (2025-12-01) -
Bone marrow mesenchymal stem cell-derived extracellular vesicles alleviate diabetes-exacerbated atherosclerosis via AMPK/mTOR pathway-mediated autophagy-related macrophage polarization
by: Libo Liu, et al.
Published: (2025-01-01) -
A comprehensive map of the mTOR signaling network
by: Etienne Caron, et al.
Published: (2010-12-01) -
Interferon regulates neural stem cell function at all ages by orchestrating mTOR and cell cycle
by: Damian Carvajal Ibañez, et al.
Published: (2023-01-01)